Scarica l'app Stockscreener
23.88
1.89%
-0.46
Dopo l'orario di chiusura:
23.88
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Precedente Chiudi:
$24.34
Aprire:
$24.21
Volume 24 ore:
444.96K
Relative Volume:
0.72
Capitalizzazione di mercato:
$1.13B
Reddito:
$723.55M
Utile/perdita netta:
$157.72M
Rapporto P/E:
7.96
EPS:
3
Flusso di cassa netto:
$170.15M
1 W Prestazione:
+0.04%
1M Prestazione:
-1.16%
6M Prestazione:
-47.49%
1 anno Prestazione:
-43.64%
Intervallo 1D:
$23.77
$24.42
Intervallo di 1 settimana:
$23.30
$25.36
Portata 52W:
$22.64
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Nome
Amphastar Pharmaceuticals Inc
Settore
Telefono
909-980-9484
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Confronta AMPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
23.88 | 1.13B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
160.41 | 66.72B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.45 | 48.08B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 47.74B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.48 | 18.49B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
308.07 | 13.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Iniziato | Wells Fargo | Equal Weight |
| 2024-03-05 | Iniziato | JP Morgan | Overweight |
| 2023-11-17 | Iniziato | BofA Securities | Neutral |
| 2023-07-25 | Ripresa | Jefferies | Buy |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2022-07-29 | Iniziato | CapitalOne | Overweight |
| 2022-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Iniziato | Northland Capital | Outperform |
| 2019-03-13 | Downgrade | Needham | Buy → Hold |
| 2019-03-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Reiterato | Needham | Buy |
| 2018-03-13 | Reiterato | Needham | Buy |
| 2017-12-01 | Reiterato | Needham | Buy |
| 2017-11-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Reiterato | Needham | Buy |
| 2017-03-14 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Reiterato | Needham | Buy |
| 2016-05-10 | Reiterato | Needham | Buy |
| 2016-02-19 | Iniziato | Wells Fargo | Outperform |
| 2015-06-19 | Reiterato | Needham | Buy |
| 2015-06-03 | Iniziato | Raymond James | Strong Buy |
| 2014-07-21 | Iniziato | Needham | Buy |
Mostra tutto
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
Amphastar outlines key launches and product growth drivers for 2025 - MSN
Amphastar Pharma (AMPH) Downgraded by JP Morgan with Revised Pri - GuruFocus
This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga
Amphastar stock rating cut to Neutral by JPMorgan - Investing.com Canada
JPMorgan Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $30 From $45 - marketscreener.com
Amphastar (AMPH) Faces Downgrade Amid Pipeline Challenges | AMPH Stock News - GuruFocus
Amphastar Pharmaceuticals, Comstock, Range Resources - TradingView
Amphastar Pharmaceuticals: Navigating Through An Inflection Year (NASDAQ:AMPH) - Seeking Alpha
Schonfeld Strategic Advisors LLC Acquires 33,007 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Trend Tracker for (AMPH) - news.stocktradersdaily.com
Dimensional Fund Advisors LP Raises Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
U.S. Naloxone Market to Witness Remarkable Growth with Amphastar Pharmaceuticals Inc., Emergent BioSolutions Inc. - openPR.com
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference - ACCESS Newswire
U.S. Naloxone Market Set to Witness Significant Growth - openPR.com
First Trust Advisors LP Acquires 63,100 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals’ Mixed Earnings Call Insights - TipRanks
43,235 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Aristeia Capital L.L.C. - MarketBeat
Amphastar Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
Amphastar (AMPH) Target Price Slashed by Wells Fargo Analyst | A - GuruFocus
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2025 Earnings Call Transcript - Insider Monkey
Amphastar Pharmaceuticals Revenue Miss: EPS Exceeds ExpectationsNews and Statistics - IndexBox
Amphastar Pharmaceuticals Reports Q1 2025 Earnings - TipRanks
Amphastar: Q1 Earnings Snapshot - The Washington Post
Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 Sales Targets - Yahoo Finance
Earnings call transcript: Amphastar Q1 2025 misses earnings, stock edges up - Investing.com Australia
Amphastar Q2 2025 slides: strategic shift to proprietary drugs amid growth challenges - Investing.com India
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings Estimates - Yahoo Finance
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025 - ACCESS Newswire
Earnings Flash (AMPH) Amphastar Pharmaceuticals Posts Q1 Adjusted EPS $0.74, vs. FactSet Est of $0.69 - marketscreener.com
Amphastar Pharmaceuticals (AMPH) Expected to Announce Earnings on Wednesday - MarketBeat
Earnings Outlook For Amphastar Pharma - Nasdaq
Amphastar Pharmaceuticals to Announce Earnings: What to ExpectNews and Statistics - IndexBox
Amphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Insider Sell: Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH) - GuruFocus
Raymond James Financial Inc. Acquires Shares of 92,904 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock? - MSN
Take off with Amphastar Pharmaceuticals Inc (AMPH): Get ready for trading - Sete News
Adversity is less terrifying than hope: Inovio Pharmaceuticals Inc (INO) - Sete News
Envestnet Asset Management Inc. Sells 2,463 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025 - Yahoo Finance
Barclays PLC Buys 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by Oberweis Asset Management Inc. - MarketBeat
Learn to Evaluate (AMPH) using the Charts - news.stocktradersdaily.com
2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of - The Globe and Mail
Anaphylaxis Treatment Market Size in 7MM is expected to grow at - openPR.com
Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest - Yahoo Finance
Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):